Internal Medicine News - Novel drug boosts smoking cessation rates: varenicline is a safe and effective treatment for breaking the smoking addiction cycle, studies find.(Psychiatry)
An experimental drug called varenicline helps smokers kick the habit better than does bupropion, the only drug currently prescribed for the task, a U.S.-Norwegian team of researchers finds.
In two studies, the researchers gave 2,045 U.S. smokers a placebo, varenicline, or bupropion–marketed as Amfebutamone, Wellbutrin, or Zyban. After 12 weeks, the quit rate was 44 percent for those getting varenicline, 30 percent for the bupropion group, and 18 percent for the placebo group, reports Serena Tonstad, a physician at Ulleval University Hospital in Oslo.
Related Results
Smoking cessation drug may be helpful for nicotine addiction in schizophrenics.
Health: Dear Doctor; Dr Mark Porter answers your questions on
Investor Alert for Shareholders of Watson Pharmaceuticals Inc.
MARKET REPORT: Investors scent another Glaxo bonus as price hits peak
Anti-smoking drug concern after 18 deaths
Varenicline is administered twice daily in pill form. The drug partially blocks a protein that sits on the surfaces of cells. When nicotine binds to this protein, it triggers release of dopamine, providing the effect that makes nicotine addictive. While varenicline causes the release of some dopamine, “the release is not as much and not as rapid as with smoking,” Tonstad says.
COPYRIGHT 2005 Science Service, Inc.
COPYRIGHT 2005 Gale Group
